ポータブル静脈ファインダーの世界市場2023年～2030年

概要

ポータブル静脈ファインダーは、患者の皮膚上の静脈のリアルタイム画像を表示することによって静脈の位置を特定します。静脈ファインダは持ち運びができないことが多いが、ポータブルのものは病院でのさまざまな患者の静脈穿刺手技の際に持ち運びが容易です。これらは、皮膚表面の静脈を見るために透過照明技術を使用するため、静脈照明器とも呼ばれます。

静脈ビューアは、精度を高め、不快感を最小限に抑え、静脈穿刺のリスクを低減します。瀉血担当者は主に、採血のための静脈の位置を確認するために静脈ビューアを使用し、手技の成功率を向上させています。静脈ファインダは合併症を減らし、患者の満足度を高め、初回採血の成功率を高めます。

市場促進要因：市場抑制要因

入院患者の増加

パンデミック（世界的大流行）の間、入院や定期的な医療検診の数が増加しました。人々の健康に対する意識の高まりにより、定期的に医師の診察を受けるようになっています。静脈ファインダは、診断、モニタリング、治療の目的で患者に行われる採血、静脈穿刺などに使用されます。入院患者の増加は静脈ファインダーの使用を増加させ、さらに市場を牽引しています。

例えば、米国病院協会（American Hospital Association）によると、2023年、6,200以上の病院と400以上の医療システムから提供されたデータによると、米国の全病院の総入院数は34,011,386です。

さらに、世界保健機関（WHO）によると、過去28日間（2023年8月～9月）の世界レベルでの新規入院患者数は9万5,999人、新規ICU（集中治療室）入院患者数は985人で、それぞれ過去28日間（2023年7月～8月）に比べ42％、12％増加しました。

オーストラリア保健福祉研究所（Australian Institute of Health and Welfare, 2023）によると、2021～22年の公立・私立病院の入院患者数は1,160万人で、前年比2.1％減少しました。これは2019～20年から2020-21年にかけての6.3％増に続くものです。

肌の色が黒い人に対する最初の失敗

PIVカテーテル挿入の初回静脈注射試行成功率は、肌の色が中程度または色黒の患者では57％であったが、肌の色が白い患者では78％でした。肌の色が黒または中程度の患者の成功率はほぼ57.1％で、肌の色が明るい患者の成功率（78％）より21％低かっています。Accuvein社によると、皮膚の色素沈着が濃い患者の場合、最初のスティックの失敗率は最大21％高くなるといわれています。静脈ファインダーは、くすんだ色や暗い色の肌にはあまり適していないです。

このレポートの詳細について- サンプル請求

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 入院患者の増加
    • 前年比
  • 抑制
    • 肌の黒い人の初回不成功
    • はい
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

• ディスプレイタイプ
• 非ディスプレイタイプ

第8章 技術別

• 近赤外線
• 可視光透過照明
• その他

第9章 エンドユーザー別

• 病院およびクリニック
• 診断センター、研究センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他のアジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• AccuVein, Inc
• Christie Medical Holdings Inc.
• Novarix
• TransLite
• Vuetek
• AMBULANC（SHENZHEN）TECH. CO. LTD.ZD Medical
• BLZ Technology
• B. Braun Medical Inc.
• Thermo Fisher Scientific Inc
• Delta Medical International Ltd

第13章 付録

Overview

Portable vein finder locates veins by showing real-time images of veins on the patient's skin. Vein finders are not often portable, but portable ones are easy to carry around during the venipuncture techniques for different patients in hospital settings. These are also called vein illuminators, as they use trans-illumination technology to view the veins on the skin's surface.

Vein viewers enhance accuracy, minimize discomfort, and reduce the risk of venipunctures. Phlebotomists mainly use vein viewers to help locate veins for blood draws, which improves the procedure's success rate. Vein finders reduce complications, increase patient satisfaction, and increase first-attempt success.

Market Dynamics: Drivers & Restraints

Increasing hospital admissions

The number of hospitalizations and regular healthcare checkups increased during the pandemic. The growing awareness about health among people is making people regularly visit doctors. Vein finders are used for patients to draw blood, venipuncture, etc., which is done to patients for diagnosis, monitoring, and treatment purposes. Increased hospital admissions increase the use of vein finders, further driving the market.

For instance, according to the American Hospital Association, 2023, per the data provided by over 6,200 hospitals and 400 healthcare systems, total admissions in all U.S. hospitals are 34,011,386.

Furthermore, according to the World Health Organization, 2023, At the global level, during the past 28 days (August to September 2023), a total of 95 999 new hospitalizations and 985 new ICU) admissions were reported, an increase of 42% and 12% respectively, compared to the previous 28 days (July to August 2023).

According to the Australian Institute of Health and Welfare, 2023, there were 11.6 million public and private hospital admissions in 2021-22, a 2.1% decrease from the previous year. This followed a 6.3% increase from 2019-20 to 2020-21.

First attempt failure in dark-skinned people

Patients with medium or dark skin color had a first IV attempt success rate of 57% for PIV catheter insertions, while fair skin color patients had a rate of 78%. The success rate for patients with dark or medium skin color was nearly 57.1%, which was 21% less than the success rate for those with light skin color (78%). According to Accuvein, the first stick attempt failure rate is up to 21% higher in patients with dark skin pigmentation. Vein finders are not so feasible on dusky and dark skin tones because the illuminated light is not visible in dark-skin-toned people.

For more details on this report - Request for Sample

Segment Analysis

The global portable vein finder is segmented based on product type, technology, end-user and region.

The transillumination segment accounted for approximately 47.3% of the market share

Transillumination uses light to illuminate the veins. The image is due to deoxyhemoglobin in the venous blood, which absorbs red light and radiates the veins as dark lines on the skin's surface. This is the easiest and most reliable way of accessing the vein on the skin's surface. Launching the vein finders using transillumination technology makes the work of clinicians easy due to its efficiency.

In April 2022, ImmunoTek Bio Centers launched the first blood plasma collection centers using VeinViewer, developed by Christie Medical Holdings, which provides phlebotomists with real-time images of the donor's veins before needle insertion.

In September 2021, NextVein LLC launched a product that makes vein visualization affordable for every clinician. The NextVein system is designed from the ground up to be a simple-to-use, cost-effective solution for successful vein access.

Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

Hospital admissions in the U.S. increased drastically in 2021; there were over 34 million hospital admissions in the United States. The number of hospitals in the U.S. has decreased in recent years, although the country faces an increasing elderly population. Predictably, the elderly account for the largest share of hospital admissions in the U.S.

For instance, according to the report published in 2023 by the Centers for Disease Control and Prevention (CDC), the total number of hospitalizations from COVID-19, flu, and syncytial virus infections this year, similar to last year, higher than pre-pandemic levels.

Although COVID-19 hospitalizations have drastically decreased since 2022, there is an increase in awareness about healthcare checkups after the pandemic. Moreover, there is an increased geriatric population in the United States and the rest of the world; hence, North America holds the largest share of the market.

COVID-19 Impact Analysis:

COVID-19 created a surge in the portable vein finder market. The number of patients visiting hospitals increased during the pandemic, which increased the use of hospital equipment and medical devices. Vein finders allow physicians to access veins easily within less time, which is less time-consuming than manually finding them on patients' skin. For almost all patients, these medical devices are used to access the vein quickly. This has increased the demand for portable vein finders during the pandemic period.

Competitive Landscape

The major global players in the portable vein finder market include: AccuVein, Inc, Christie Medical Holdings Inc., Novarix, TransLite, Vuetek, AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical, BLZ Technology, B. Braun Medical Inc., ThermoFisher Scientific Inc, Delta Medical International Ltd among others.

Key Developments

• In October 2022, Right Way Medical, a medical device distributor is in partnership with NextVein, to increase patient satisfaction. It uses augmented reality to project the vein pattern on patient skin, bringing clarity and simplicity to clinicians.

Why Purchase the Report?

• To visualize the global portable vein finder market segmentation based on product type, technology, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of portable vein finder market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global portable vein finder market report would provide approximately 61 tables, 51 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Driver
    • 4.1.1.1. Increasing hospital admissions
    • 4.1.1.2.
  • 4.1.2. Restraints
    • 4.1.2.1. First attempt failure in dark-skinned people
    • 4.1.2.2.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Display type*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Non-Display Type

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Near-infrared*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Visible light trans illumination
• 8.4. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals and Clinics*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Diagnostic centers and Research Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. AccuVein, Inc
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Christie Medical Holdings Inc.
• 12.3. Novarix
• 12.4. TransLite
• 12.5. Vuetek
• 12.6. AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical
• 12.7. BLZ Technology
• 12.8. B. Braun Medical Inc.
• 12.9. Thermo Fisher Scientific Inc
• 12.10. Delta Medical International Ltd

LIST NOT EXHAUSTIVE.

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us